| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ADAM metallopeptidase domain 8 | 0.590 | 0.731 | 2.2E-14 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
cyclin dependent kinase inhibitor 3 | 0.514 | 0.769 | 1.9E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2002 | 2002 | ||||||||
|
ADAM metallopeptidase domain 28 | 0.666 | 0.500 | 3.0E-24 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
claudin 3 | 0.558 | 0.615 | 0.52 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
growth hormone releasing hormone | 0.503 | 0.769 | 0.15 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2008 | 2008 | ||||||||
|
kallikrein related peptidase 3 | 0.443 | 0.885 | 4.4E-06 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1997 | 1997 | ||||||||
|
microRNA 16-2 | 0.736 | 0.346 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | |||||||||
|
microRNA 19a | 0.512 | 0.808 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2016 | 2016 | |||||||||
|
microRNA 30e | 0.576 | 0.769 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2011 | 2011 | |||||||||
|
myosin heavy chain 9 | 0.505 | 0.808 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
activating transcription factor 3 | 0.494 | 0.885 | 8.9E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
developmentally regulated GTP binding protein 1 | 0.682 | 0.346 | 0.33 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1997 | 1997 | ||||||||
|
NHS actin remodeling regulator | 0.466 | 0.846 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
proprotein convertase subtilisin/kexin type 6 | 0.626 | 0.538 | 5.3E-13 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2013 | 2013 | ||||||||
|
paxillin | 0.547 | 0.654 | 8.2E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2005 | 2005 | ||||||||
|
tripartite motif containing 27 | 0.572 | 0.808 | 1.00 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2005 | 2005 | ||||||||
|
interferon induced with helicase C domain 1 | 0.471 | 0.808 | 7.0E-44 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
bromodomain testis associated | 0.751 | 0.231 | 5.8E-09 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2005 | 2005 | ||||||||
|
sulfite oxidase | 0.638 | 0.615 | 9.4E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
LIM homeobox 3 | 0.644 | 0.462 | 1.1E-02 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
interleukin 13 | 0.386 | 0.846 | 1.4E-02 |
|
disease | 0.040 | None | 0.500 | 3 | 0 | 1999 | 2012 | ||||||||
|
defensin beta 4B | 0.510 | 0.769 | 6.8E-02 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 1999 | 2001 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 1998 | 2004 | ||||||||
|
dual specificity phosphatase 6 | 0.511 | 0.846 | 0.98 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2011 | 2018 | ||||||||
|
G protein nucleolar 3 | 0.579 | 0.577 | 2.0E-19 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2012 | 2014 |